Toronto Dominion Bank’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Toronto Dominion Bank’s Portfolio QNTM Stock Details QNTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Hold	0	–	-$12	–	1849
2023 Q3	–	Sell	-1	Closed	-$82	–	1805
2023 Q2	$0	Hold	1	–	–	﹤0.01%	1841
2023 Q1	$0	Buy	+1	New	+$86	﹤0.01%	1750
2022 Q3	–	Sell	-5	Closed	–	–	1744
2022 Q2	$0	Buy	5 +4	+400%	+$240	﹤0.01%	1958
2022 Q1	$0	Buy	+1	New	+$61	﹤0.01%	2068
2021 Q4	–	Sell	-1	Closed	–	–	2072
2021 Q3	$0	Sell	1 -4	-80%	-$427	﹤0.01%	1498
2021 Q2	$1K	Buy	5 +4	+400%	+$464	﹤0.01%	1349
2021 Q1	$0	Sell	1 -7	-88%	-$979	﹤0.01%	1596
2020 Q4	$1K	Buy	8 +3	+60%	+$354	﹤0.01%	1331
2020 Q3	$1K	Buy	5 +4	+400%	+$831	﹤0.01%	1210
2020 Q2	$0	Sell	1 -1	-50%	-$234	﹤0.01%	1395
2020 Q1	$0	Buy	+2	New	+$662	﹤0.01%	1491

Other funds holding QNTM

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Toronto Dominion Bank's QNTM Position: Q4 2023 in Review

Toronto Dominion Bank held its Quantum Biopharma Class B Subordinate Voting Shares (QNTM) position steady in Q4 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1849.

Toronto Dominion Bank first reported a position in QNTM in Q1 2020 and has held it in 11 quarters since. The position peaked at $1K in Q2 2021. 14 funds tracked by Wall St. Rank hold QNTM as of Q4 2023.

Toronto Dominion Bank held 0 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $0 as of Q4 2023.
Toronto Dominion Bank left its Quantum Biopharma Class B Subordinate Voting Shares share count unchanged in Q4 2023.
Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q4 2023, its #1849 holding.
Toronto Dominion Bank first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q1 2020 and has held it in 11 quarters since.
Toronto Dominion Bank's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $1K in Q2 2021.
14 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q4 2023.

Based on Toronto Dominion Bank's 13F filing for Q4 2023, filed 13 Feb 2024.